{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T02:10:02Z","timestamp":1725588602765},"reference-count":35,"publisher":"Japanese Society of Veterinary Science","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Vet. Med. Sci.","The Journal of Veterinary Medical Science"],"published-print":{"date-parts":[[2011]]},"DOI":"10.1292\/jvms.11-0093","type":"journal-article","created":{"date-parts":[[2011,6,7]],"date-time":"2011-06-07T05:21:12Z","timestamp":1307424072000},"page":"1295-1302","source":"Crossref","is-referenced-by-count":5,"title":["Screening of Therapeutic Targets for Canine Mast Cell Tumors from a Variety of Kinase Molecules"],"prefix":"10.1292","volume":"73","author":[{"given":"Yoshinori","family":"TAKEUCHI","sequence":"first","affiliation":[{"name":"Department of Veterinary Internal Medicine, Graduate School of Agricultural and Life Sciences, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhito","family":"FUJINO","sequence":"additional","affiliation":[{"name":"Department of Veterinary Internal Medicine, Graduate School of Agricultural and Life Sciences, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"WATANABE","sequence":"additional","affiliation":[{"name":"Laboratory of Functional Genomics, Department of Medical Genome Sciences, Graduate School of Frontier Sciences, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"NAKAGAWA","sequence":"additional","affiliation":[{"name":"Department of Veterinary Surgery, Graduate School of Agricultural and Life Sciences, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"OHNO","sequence":"additional","affiliation":[{"name":"Department of Veterinary Internal Medicine, Graduate School of Agricultural and Life Sciences, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"SASAKI","sequence":"additional","affiliation":[{"name":"Department of Veterinary Surgery, Graduate School of Agricultural and Life Sciences, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumio","family":"SUGANO","sequence":"additional","affiliation":[{"name":"Laboratory of Functional Genomics, Department of Medical Genome Sciences, Graduate School of Frontier Sciences, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime","family":"TSUJIMOTO","sequence":"additional","affiliation":[{"name":"Department of Veterinary Internal Medicine, Graduate School of Agricultural and Life Sciences, The University of Tokyo"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"122","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2010.03.001"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Buitenhuis, M., Coffer, P. J. and Koenderman, L. 2004. Signal transducer and activator of transcription 5 (STAT5). Int. J. Biochem. Cell Biol. 36: 2120-2124.","DOI":"10.1016\/j.biocel.2003.11.008"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-010-0454-z"},{"key":"4","unstructured":"4. Carnero, A., Blanco-Aparicio, C., Renner, O., Link, W. and Leal, J. F. 2008. The PTEN\/PI3K\/AKT signalling pathway in cancer, therapeutic implications. Curr. Cancer Drug Targets 8: 187-198."},{"key":"5","unstructured":"5. Castano, J., Davalos, V., Schwartz, S. Jr. and Arango, D. 2008. EPH receptors in cancer. Histol. Histopathol. 23: 1011-1023."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Dai, Y. 2010. Platelet-derived growth factor receptor tyrosine kinase inhibitors: a review of the recent patent literature. Expert Opin. Ther. Pat. 20: 885-897.","DOI":"10.1517\/13543776.2010.493559"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1111\/j.1748-5827.2007.00366.x"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2008.00742.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Gleixner, K. V., Rebuzzi, L., Mayerhofer, M., Gruze, A., Hadzijusufovic, E., Sonneck, K., Vales, A., Kneidinger, M., Samorapoompichit, P., Thaiwong, T., Pickl, W. F., Yuzbasiyan-Gurkan, V., Sillaber, C., Willmann, M. and Valent, P. 2007. Synergistic antiproliferative effects of KIT tyrosine kinase inhibitors on neoplastic canine mast cells. Exp. Hematol. 35: 1510-1521.","DOI":"10.1016\/j.exphem.2007.06.005"},{"issue":"6","key":"10","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1111\/j.1939-1676.2008.0190.x","volume":"22","author":"HAHN K. A.","year":"2008","ISSN":"http:\/\/id.crossref.org\/issn\/0891-6640","issn-type":"print"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ishizuka, M., Nagai, S., Sakamoto, K. Q. and Fujita, S. 2007. Plasma pharmacokinetics and CYP3A12-dependent metabolism of c-kit inhibitor imatinib in dogs. Xenobiotica 37: 503-513.","DOI":"10.1080\/00498250600962849"},{"issue":"4","key":"12","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1939-1676.2008.00132.x","volume":"22","author":"ISOTANI M.","year":"2008","ISSN":"http:\/\/id.crossref.org\/issn\/0891-6640","issn-type":"print"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.2460\/ajvr.69.7.938"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Konopatskaya, O. and Poole, A. W. 2010. Protein kinase Calpha: disease regulator and therapeutic target. Trends Pharmacol. Sci. 31: 8-14.","DOI":"10.1016\/j.tips.2009.10.006"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-08-0067"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2001-12-0350"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Lin, T. Y., Bear, M., Du, Z., Foley, K. P., Ying, W., Barsoum, J. and London, C. 2008. The novel HSP90 inhibitor STA-9090 exhibits activity against Kit-dependent and -independent malignant mast cell tumors. Exp. Hematol. 36: 1266-1277.","DOI":"10.1016\/j.exphem.2008.05.001"},{"key":"18","unstructured":"18. Lin, T. Y., Fenger, J., Murahari, S., Bear, M. D., Kulp, S. K., Wang, D., Chen, C. S., Kisseberth, W. C. and London, C. A. 2010. AR-42, a novel HDAC inhibitor, exhibits biologic activity against malignant mast cell lines via down-regulation of constitutively activated Kit. Blood 115: 4217-4225."},{"key":"19","unstructured":"19. Linger, R. M., Keating, A. K., Earp, H. S. and Graham, D. K. 2008. TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer. Adv. Cancer Res. 100: 35-83."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Lok, W., Klein, R. Q. and Saif, M. W. 2010. Aurora kinase inhibitors as anti-cancer therapy. Anticancer Drugs 21: 339-350.","DOI":"10.1097\/CAD.0b013e3283350dd1"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-472X(98)00075-7"},{"key":"22","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-1860"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1999.00488.x"},{"key":"24","unstructured":"24. Malone, E. K., Rassnick, K. M., Wakshlag, J. J., Russell, D. S., Al-Sarraf, R., Ruslander, D. M., Johnson, C. S. and Trump, D. L. 2010. Calcitriol (1,25-dihydroxycholecalciferol) enhances mast cell tumour chemotherapy and receptor tyrosine kinase inhibitor activity in vitro and has single-agent activity against spontaneously occurring canine mast cell tumours. Vet. Comp. Oncol. 8: 209-220."},{"key":"25","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetimm.2008.06.014"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2010.05.004"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbpa.2010.03.019"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Rebuzzi, L., Willmann, M., Sonneck, K., Gleixner, K. V., Florian, S., Kondo, R., Mayerhofer, M., Vales, A., Gruze, A., Pickl, W. F., Thalhammer, J. G. and Valent, P. 2007. Detection of vascular endothelial growth factor (VEGF) and VEGF receptors Flt-1 and KDR in canine mastocytoma cells. Vet. Immunol. Immunopathol. 115: 320-333.","DOI":"10.1016\/j.vetimm.2006.11.009"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.03.7689"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2007.05884.x"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1159\/000053820"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Takeuchi, Y., Fujino, Y., Fukushima, K., Watanabe, M., Nakagawa, T., Ohno, K., Sasaki, N., Sugano, S. and Tsujimoto, H. 2011. Biological effect of tyrosine kinase inhibitors on three canine mast cell tumor cell lines with various KIT statuses. J. Vet. Pharmacol. Ther. (in press).","DOI":"10.1111\/j.1365-2885.2011.01296.x"},{"key":"33","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetimm.2010.05.009"},{"key":"34","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2793"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3164.2008.00694.x"}],"container-title":["Journal of Veterinary Medical Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jvms\/73\/10\/73_11-0093\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T07:58:56Z","timestamp":1617004736000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jvms\/73\/10\/73_11-0093\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1292\/jvms.11-0093","relation":{},"ISSN":["0916-7250","1347-7439"],"issn-type":[{"value":"0916-7250","type":"print"},{"value":"1347-7439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011]]}}}